Table 2 p-values and relationship between vitronectin and nuclei morphometric measurements and poor prognostic factors
From: Vitronectin as a molecular player of the tumor microenvironment in neuroblastoma
Parameter | Age: ≥18 months | Stage: M | Hist.D: uNB/pdNB | MYCN: MNA | Gen. profile: SCA | 11q: 11qD | Risk group: high-risk | Gen. Instab.:High | ||
|---|---|---|---|---|---|---|---|---|---|---|
IPP | Nuclei | Dens. | – | 0.005↑ | 0.007↑ | 0.001↑ | – | – | 0.001↑ | 0.003↑ |
%SA | 0.004↑ | – | – | – | 0.018↓ | – | – | – | ||
Inter.VN | %SA | – | – | – | – | – | – | – | – | |
Terr.VN | %SA | – | 0.010↑ | 0.001↑* | 0.024↑ | 0.001↑ | 0.035↑ | 0.008↑ | 0.000↑ | |
Densito | VN ratio of pixels | Weak | – | – | – | – | – | – | – | – |
Mod. | – | – | – | – | – | – | – | – | ||
Strong | – | 0.037↑ | 0.010↑* | 0.011↑ | 0.002↑ | 0.021↑ | 0.004↑ | 0.010 ↑ | ||
H-score | – | – | 0.019↑ | 0.040↑ | 0.011↑ | – | 0.008↑ | 0.001↑ | ||